Phase IIA trial of bupropion/trazodone for male hypoactive sexual desire disorder.

Trial Profile

Phase IIA trial of bupropion/trazodone for male hypoactive sexual desire disorder.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Bupropion/trazodone (Primary)
  • Indications Decreased libido
  • Focus Therapeutic Use
  • Sponsors S1 Biopharma
  • Most Recent Events

    • 20 Aug 2015 Results published in the Media Release.
    • 19 Aug 2015 Status changed from not yet recruiting to active, no longer recruiting according to an S1 Biopharma media release.
    • 03 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top